<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01312441</url>
  </required_header>
  <id_info>
    <org_study_id>00741</org_study_id>
    <secondary_id>10-023</secondary_id>
    <nct_id>NCT01312441</nct_id>
  </id_info>
  <brief_title>Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D</brief_title>
  <official_title>Sustainability of 25-hydroxyvitamin D Levels, Inflammatory Reduction, and Endothelial Dysfunction After Repletion With Ergocalciferol in CKD Stage 5D</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albany College of Pharmacy and Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hortense &amp; Louis Rubin Dialysis Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Satellite Healthcare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Albany College of Pharmacy and Health Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The prevalence of vitamin D deficiency increases as kidney function declines. As a result,
      many hemodialysis patients often have low levels of vitamin D. Recent evidence has shown that
      vitamin D supplementation may improve many aspects of poor health such as heart disease and
      inflammatory markers. The objectives of this study are to determine how supplementing
      dialysis patients with ergocalciferol increases vitamin D levels, how long vitamin D levels
      can be maintained after a 6 month treatment course, and to examine the effect of
      ergocalciferol on biomarkers of inflammation and vascular health.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low enrollment
  </why_stopped>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The sustainability of 25-hydroxy-vitamin D levels after 6 months of vitamin D replenishment with ergocalciferol</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Renal Failure Chronic Requiring Hemodialysis</condition>
  <arm_group>
    <arm_group_label>Ergocalciferol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ergocalciferol 50,000 IU by mouth once weekly for 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo by mouth once weekly for 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ergocalciferol</intervention_name>
    <description>Ergocalciferol capsules 50,000 IU once weekly for 6 months</description>
    <arm_group_label>Ergocalciferol</arm_group_label>
    <other_name>Drisdol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo by mouth once weekly for 6 months</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Activated vitamin D administration

          -  On chronic hemodialysis for ≥ 6 months

          -  Use of a synthetic biocompatible dialysis membrane

          -  25-hydroxyvitamin D levels &lt; 30 ng/mL

          -  Corrected serum calcium &lt; 10.2 mg/dL

          -  Serum phosphate &lt; 7 mg/dL

          -  Iron replete (Ferritin &gt; 200 ng/mL and transferrin saturation &gt; 20%)

        Exclusion Criteria:

          -  Current participation in any other investigational drug trial

          -  Vitamin D deficiency due to a heredity disorder

          -  Liver disease or failure

          -  Current or past treatment with ergocalciferol or cholecalciferol ≥ 2000 IU per day
             (within the past 6 months)

          -  Treatment with calcimimetics or bisphosphonates within the last 3 months

          -  Treatment with anti-epileptics or other medications that can effect vitamin D
             metabolism

          -  Malnutrition (serum albumin &lt; 2.5 mg/dL)

          -  Pregnancy, positive pregnancy test or breastfeeding

          -  Malignancy or other significant inflammatory disease

          -  HIV/AIDS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Darius L Mason, Pharm.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albany College of Pharmacy and Health Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Roy Mathew, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stratton Veteran Affairs Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stratton VA Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hortense and Louis Rubin Dialysis Center</name>
      <address>
        <city>Clifton Park</city>
        <state>New York</state>
        <zip>12065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hortense and Louis Rubin Dialysis Center</name>
      <address>
        <city>Saratoga Springs</city>
        <state>New York</state>
        <zip>12866</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hortense and Louis Rubin Dialysis Center</name>
      <address>
        <city>Troy</city>
        <state>New York</state>
        <zip>12180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2011</study_first_submitted>
  <study_first_submitted_qc>March 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2011</study_first_posted>
  <last_update_submitted>January 13, 2016</last_update_submitted>
  <last_update_submitted_qc>January 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Albany College of Pharmacy and Health Sciences</investigator_affiliation>
    <investigator_full_name>Darius Mason</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Ergocalciferol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

